,XOR-IDH3α

Yijun Lu1, Qikai Sun2, Qifei Guan1

  • 1Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.

Journal of hepatology
|July 20, 2023
PubMed
概括

在与瘤相关的巨细胞中,丁氧化还原酶 (XOR) 损失通过增强M2极化和CD8+T细胞耗尽,促进肝细胞癌 (HCC) 的进展. 准XOR-IDH3α轴可能为HCC提供新的免疫治疗策略.